Medartis Holding AG (SWX: MED)
Switzerland
· Delayed Price · Currency is CHF
48.85
+3.80 (8.44%)
Nov 20, 2024, 5:30 PM CET
Medartis Holding AG Company Description
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide.
Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery.
The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.
It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.
Medartis Holding AG
Country | Switzerland |
Founded | 1997 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 876 |
CEO | Matthias Schupp |
Contact Details
Address: Hochbergerstrasse 60E Basel, 4057 Switzerland | |
Phone | 41 61 633 34 34 |
Website | medartis.com |
Stock Details
Ticker Symbol | MED |
Exchange | SIX Swiss Exchange |
Fiscal Year | January - December |
Reporting Currency | CHF |
ISIN Number | CH0386200239 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Dr. Thomas Straumann | Founder and Vice Chairman |
Mareike Loch | Vice President of EMEA and Member of Executive Management Board |
Manuel Schaer | Chief Technology Officer and Member of the Executive Board |
Mario Della Casa | Chief Operating Officer and Member of Management Board |
Inge Maes | Chief Human Resources Officer and Executive Management Board Member |
Anisha Wharton | Head of Regulatory Affairs |